These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28930610)

  • 1.
    Pereira HS; Soares Lima SC; de Faria PS; Cardoso LC; Seuanez HN
    Front Biosci (Elite Ed); 2018 Jan; 10(1):143-154. PubMed ID: 28930610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer.
    Wagner KJ; Cooper WN; Grundy RG; Caldwell G; Jones C; Wadey RB; Morton D; Schofield PN; Reik W; Latif F; Maher ER
    Oncogene; 2002 Oct; 21(47):7277-82. PubMed ID: 12370819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of AURKC expression by CpG island methylation in human cancer cells.
    Fujii S; Srivastava V; Hegde A; Kondo Y; Shen L; Hoshino K; Gonzalez Y; Wang J; Sasai K; Ma X; Katayama H; Estecio MR; Hamilton SR; Wistuba I; Issa JP; Sen S
    Tumour Biol; 2015 Sep; 36(10):8147-58. PubMed ID: 25990457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation changes in promoter and enhancer regions of the WT1 gene in Wilms' tumours.
    Mares J; Kríz V; Weinhäusel A; Vodicková S; Kodet R; Haas OA; Sedlácek Z; Goetz P
    Cancer Lett; 2001 May; 166(2):165-71. PubMed ID: 11311489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
    Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
    Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.
    Dallosso AR; Hancock AL; Szemes M; Moorwood K; Chilukamarri L; Tsai HH; Sarkar A; Barasch J; Vuononvirta R; Jones C; Pritchard-Jones K; Royer-Pokora B; Lee SB; Owen C; Malik S; Feng Y; Frank M; Ward A; Brown KW; Malik K
    PLoS Genet; 2009 Nov; 5(11):e1000745. PubMed ID: 19956686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.
    Morris MR; Hesson LB; Wagner KJ; Morgan NV; Astuti D; Lees RD; Cooper WN; Lee J; Gentle D; Macdonald F; Kishida T; Grundy R; Yao M; Latif F; Maher ER
    Oncogene; 2003 Oct; 22(43):6794-801. PubMed ID: 14555992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis.
    Hancock AL; Brown KW; Moorwood K; Moon H; Holmgren C; Mardikar SH; Dallosso AR; Klenova E; Loukinov D; Ohlsson R; Lobanenkov VV; Malik K
    Hum Mol Genet; 2007 Feb; 16(3):343-54. PubMed ID: 17210670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms' tumor-specific methylation pattern in 11p13 detected by PFGE.
    Royer-Pokora B; Schneider S
    Genes Chromosomes Cancer; 1992 Sep; 5(2):132-40. PubMed ID: 1381949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in Wilms' tumor.
    Malik K; Salpekar A; Hancock A; Moorwood K; Jackson S; Charles A; Brown KW
    Cancer Res; 2000 May; 60(9):2356-60. PubMed ID: 10811108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between mRNA expression and promoter methylation status of p73 gene in peripheral blood among children with Wilms' tumor].
    Song DJ; Yue LF; Zhang D; Yang HY; Fan YX; Yue M; Pei H; Wang JX
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):638-43. PubMed ID: 23965876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA methylation landscape of five pediatric-tumor types.
    Parker AC; Quinteros BI; Piccolo SR
    PeerJ; 2022; 10():e13516. PubMed ID: 35707123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
    Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
    Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes Controlled by DNA Methylation Are Involved in Wilms Tumor Progression.
    Guerra JVDS; Pereira BMS; Cruz JGVD; Scherer NM; Furtado C; Montalvão de Azevedo R; Oliveira PSL; Faria P; Boroni M; de Camargo B; Maschietto M
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis.
    Płuciennik E; Nowakowska M; Wujcicka WI; Sitkiewicz A; Kazanowska B; Zielińska E; Bednarek AK
    Oncol Rep; 2012 Oct; 28(4):1417-22. PubMed ID: 22842668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1 alters DNA methylation levels in promoter and enhancer regions of the WT1 gene in human podocytes.
    Hamatani H; Sakairi T; Ikeuchi H; Kaneko Y; Maeshima A; Nojima Y; Hiromura K
    Nephrology (Carlton); 2019 May; 24(5):575-584. PubMed ID: 29851165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of promoter methylation and expression of SIX2 as a diagnostic and prognostic biomarker in Wilms' tumor.
    Song D; Yue L; Wu G; Ma S; Guo L; Yang H; Liu Q; Zhang D; Xia Z; Wang L; Zhang J; Zhao W; Guo F; Wang J
    Tumour Biol; 2015 Sep; 36(10):7591-8. PubMed ID: 25921281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.